Recro Pharma PE Ratio 2014-2019 | REPH

Current and historical p/e ratio for Recro Pharma (REPH) from 2014 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Recro Pharma PE ratio as of July 23, 2019 is 0.00.
Recro Pharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-23 9.79 0.00
2019-03-31 5.86 $-3.28 0.00
2018-12-31 7.10 $-3.83 0.00
2018-09-30 7.11 $-3.18 0.00
2018-06-30 5.02 $-3.02 0.00
2018-03-31 11.01 $-2.88 0.00
2017-12-31 9.25 $-2.65 0.00
2017-09-30 8.98 $-2.19 0.00
2017-06-30 7.03 $-2.21 0.00
2017-03-31 8.74 $-2.56 0.00
2016-12-31 8.06 $-2.85 0.00
2016-09-30 8.84 $-0.91 0.00
2016-06-30 7.95 $-0.65 0.00
2016-03-31 5.97 $0.01 0.00
2015-12-31 9.00 $0.19 47.37
2015-09-30 12.03 $-1.39 0.00
2015-06-30 12.92 $-1.76 0.00
2015-03-31 9.07 $-1.95 0.00
2014-12-31 2.86 $-1.62 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.220B $0.077B
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.495B 35.46
Astellas Pharma (ALPMY) Japan $28.364B 13.91
Takeda Pharmaceutical (TAK) Japan $26.810B 7.87
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.587B 26.80
Grifols, S.A (GRFS) Spain $15.360B 19.43
Merck (MKGAF) Germany $13.803B 18.84
IPSEN SA ADR (IPSEY) France $10.823B 0.00
Ionis Pharmaceuticals (IONS) United States $9.665B 21.13
Sage Therapeutics (SAGE) United States $9.265B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Catalent (CTLT) United States $8.006B 32.13
Neurocrine Biosciences (NBIX) United States $7.926B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.569B 10.38
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.637B 9.19
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.829B 16.97
Evotec AG (EVTCY) Germany $4.364B 46.84
FibroGen (FGEN) United States $4.115B 0.00
Tilray (TLRY) Canada $4.103B 0.00
United Therapeutics (UTHR) United States $3.279B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.187B 11.44
Arrowhead Pharmaceuticals (ARWR) United States $2.843B 428.29
PTC Therapeutics (PTCT) United States $2.582B 0.00
Xencor (XNCR) United States $2.503B 68.34
Zogenix (ZGNX) United States $2.041B 0.00
Portola Pharmaceuticals (PTLA) United States $1.819B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.695B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.637B 79.28
Enanta Pharmaceuticals (ENTA) United States $1.623B 22.17
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.466B 12.74
Heron Therapeutics (HRTX) United States $1.440B 0.00
Corcept Therapeutics (CORT) United States $1.261B 18.00
ArQule (ARQL) United States $1.196B 0.00
Aerie Pharmaceuticals (AERI) United States $1.029B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.027B 3.70
Theravance Biopharma (TBPH) Cayman Islands $1.016B 0.00
Radius Health (RDUS) United States $1.006B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.857B 0.00
Concordia (CXRXF) Canada $0.716B 0.00
Endo (ENDP) Ireland $0.710B 1.14
Aptorum Group (APM) China $0.648B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.570B 0.00
Organogenesis Holdings (ORGO) United States $0.539B 0.00
TherapeuticsMD (TXMD) United States $0.536B 0.00
Karyopharm Therapeutics (KPTI) United States $0.507B 0.00
Translate Bio (TBIO) United States $0.490B 0.00
ChemoCentryx (CCXI) United States $0.481B 0.00
Dermira (DERM) United States $0.458B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.453B 22.86
Catalyst Pharmaceuticals (CPRX) United States $0.452B 0.00
Akebia Therapeutics (AKBA) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.445B 1.05
Dova Pharmaceuticals (DOVA) United States $0.440B 0.00
GlycoMimetics (GLYC) United States $0.422B 0.00
CV Sciences (CVSI) United States $0.410B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.406B 0.00
Flexion Therapeutics (FLXN) United States $0.401B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
Indivior (INVVY) United States $0.392B 1.42
CannTrust Holdings (CTST) Canada $0.386B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.370B 0.00
Harpoon Therapeutics (HARP) United States $0.365B 0.00
Xeris Pharmaceuticals (XERS) United States $0.345B 0.00
ImmunoGen (IMGN) United States $0.342B 0.00
Collegium Pharmaceutical (COLL) United States $0.339B 0.00
Lannett Co Inc (LCI) United States $0.331B 3.21
KalVista Pharmaceuticals (KALV) United States $0.319B 0.00
Rafael Holdings (RFL) United States $0.297B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.274B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
OptiNose (OPTN) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.232B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.212B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.196B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 56.38
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Calithera Biosciences (CALA) United States $0.162B 0.00
DURECT (DRRX) United States $0.158B 0.00
Ardelyx (ARDX) United States $0.149B 0.00
IMV INC (IMV) Canada $0.147B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.146B 0.00
Jounce Therapeutics (JNCE) United States $0.137B 0.00
MEI Pharma (MEIP) United States $0.126B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.122B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
Majesco Entertainment (PTE) United States $0.111B 0.00
Generex Biotechnology (GNBT) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.101B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
MediWound (MDWD) Israel $0.100B 0.00
RENEURON GP (RNUGF) United Kingdom $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Infinity Pharmaceuticals (INFI) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Mast Therapeutics (SVRA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 62.89
Genocea Biosciences (GNCA) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 748.00
Nivalis Therapeutics (ALPN) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Capnia (SLNO) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.080B 7.95
Cardiome Pharma (CORV) Canada $0.078B 0.00
China SXT Pharmaceuticals (SXTC) China $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.071B 0.00
Novan (NOVN) United States $0.069B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
India Globalization Capital (IGC) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Melinta Therapeutics (MLNT) United States $0.047B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.40
Cyanotech (CYAN) United States $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00